Rubin Lab

RUBIN’S REFLECTIONS

Follow on Twitter @IBDMD

Message to Dr. Rubin’s Patients Related to COVID-19 Boosters

Dear Friends and Patients, I hope this message finds you well. Please excuse the group nature of this message, but I did want to reach out with the latest update about COVID-19, and vaccinations. If you want to skip right to the booster info, scroll down to #5 below....

Tweetorial to Provide Updates on COVID-19 for Patients with IBD

View Twitter Thread To watch me deliver the full lecture and view the presentation, click here. I recently gave a lecture about COVID-19 and vaccination with specific information for patients with IBD. This lecture was recorded on July 21st, before the CDC issued...

SARS Vaccine and IBD Tweetorial Summary from December 1

SARS Vaccine and IBD Tweetorial Summary from December 1 David T. Rubin View Twitter Thread Here are my thoughts and a few updates about SARS-CoV-2 vaccines, and also about important implications for our IBD patients. Development of multiple SARS-CoV-2 vaccines in the...

Three waves of Illness from the COVID-19 Pandemic

By David T. Rubin, MD, Professor of Medicine, University of Chicago Medicine I've been thinking about what comes next, and how can we get ahead of this, and propose the following for consideration. I believe that there will be three waves of illness from the...

Read Dr. Rubin’s Comments on New Study Comparing HRQoL of Laparoscopic Ileocaecal Resection and Infliximab Treatment

Surgery an Alternative to Infliximab for Some People With Crohn’s Disease By Marilynn Larkin Dr. David Rubin, Chief of the Section of Gastroenterology, Hepatology, and Nutrition at the University of Chicago Medicine, agreed: “For some patients, as difficult as it may...

Three waves of Illness from the COVID-19 Pandemic

By David T. Rubin, MD, Professor of Medicine, University of Chicago Medicine I've been thinking about what comes next, and how can we get ahead of this, and propose the following for consideration. I believe that there will be three waves of illness from the...

Dr. Rubin Taps in on “IBD Community Throwing Elbows Over Value of TDM” in Gastroenterology and Endoscopy News

Dr. Mark Silverberg, Dr. David T Rubin, Dr. Laura Targownik, and Dr. Charabaty excitingly discuss why IBD specialists are divided on the topic of therapeutic drug monitoring (TDM). “If the drug is going to work but isn’t present in the body, it doesn’t do its job,”...

Pregnancy in the Setting of the SARS-CoV-2 Pandemic

By David T. Rubin, MD, Professor of Medicine, University of Chicago Medicine Dear Colleagues, A lot of concern has recently come up regarding pregnancy in the setting of the SARS-CoV-2 pandemic. Here are some key points I found on this issue: Pregnancy is a state of...

Dr. David T. Rubin on the 100th Episode of Bowel Moments Podcast

Meet Dr. David T Rubin - EPISODE 100! https://open.spotify.com/episode/6X8hREclFmnUuINrdrqxmf?si=ZxP6SD3kQ6y0hS48551Fjw

Dr. David Rubin receives the Bruce and Cynthia Sherman Charitable Foundation’s 2020 Sherman Prize

Dr. Rubin was recently announced as one of three recipients of the 2020 Sherman Prize. Sherman Prize recipients "are outstanding individuals who consider the whole patient experience — not just the serious symptoms, but also the psychological and practical components...

G&E News Expert Picks by Dr. Rubin: Best of ECCO 2019

'In this installment of “Expert Picks,” David Rubin, MD, the Joseph B. Kirsner Professor of Medicine; the chief of the Section of Gastroenterology, Hepatology, and Nutrition; and a co-director of the Digestive Diseases Center at the University of Chicago Medicine and...

IBD Management: Mastering Recent Guideline Updates to Optimize Patient-Centered Solutions

  IBD Management: Mastering Recent Guideline Updates to Optimize Patient-Centered Solutions https://www.healio.com/cme/gastroenterology/20250825/ibd-management-mastering-recent-guideline-updates/overview...

Approach to Management and Interpretation of Testing Results in Patients with IBD, with Particular Attention to Restarting Therapy

By David T. Rubin, MD, Professor of Medicine, University of Chicago Medicine As testing for SARS-CoV-2 is expanded and serologic antibody testing becomes available, we are faced with a number of different clinical scenarios. I have outlined the different situations...

Definition of “healing” and sustained remission

The FDA and others have been interested in the role of histology for assessing “deeper” levels of disease control, with the premise that biopsy may reflect the state of the disease more accurately and perhaps more objectively than endoscopy, and certainly more than...